Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

As India remains the thalassemia capital of the world, the Thalassemia Patients Advocacy Group (TPAG) has written an open ...

Due to the unique immunological characteristics of the liver, a hepatic immune-related adverse events has also been reported, which is usually termed Immune-mediated hepatitis (IMH ... Furthermore, ...

In this review, we summarize the current knowledge about how RNA viruses, including influenza virus, poliovirus, coxsackievirus, enterovirus 71, Japanese encephalitis virus, hepatitis C virus, and ...

Finding offers potential new target for treatmentPsoriasis, a painful and uncomfortable inflammatory skin condition that ...

Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

No patients reported adverse events attributable to TCV and no patients stopped their treatment ... infection and community awareness efforts in 2SLGBTQI+ venues. The Public Health Agency of Canada’s ...

Jan. 31, 2025 — In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system.

A groundbreaking new treatment is set to save babies lives by protecting them against a deadly virus. The one-off therapy, nirsevimab, is designed to protect again illness from respiratory ...

Also, a person who has persistent fevers, severe coughing and trouble catching their breath may need additional medical treatment to help stabilize them. They may also not have a virus — or ...